Anthropic Keeps IPO Range at $70 to $78 a Share in Nov. 17 Amendment
Key Facts
Anthropic filed its third amendment to its registration statement with the U.S. Securities and Exchange Commission on Nov. 17, 2026, estimating an initial public offering price of $70 to $78 a share. The amendment did not include a final price, and the range remained an estimate in the disclosure. The filing comes as the company prepares to offer 825 million Class A shares alongside a large private placement. The disclosure shows the deal combines the sale of new shares by the company with existing shares held by current shareholders. It also sets out the proposed listing terms and the mechanism for beginning sales to the public.
Anthropic plans to issue 801,351,354 of the shares offered, while current shareholders will sell 23,648,646 shares. The company will receive no proceeds from shareholders’ sale of their shares, according to the prospectus. The disclosure allows underwriters to buy up to 123,750,000 additional shares from the company at the offering price, less underwriting commissions. This remains an option for the underwriters and does not change the base number of shares offered unless exercised. These figures distinguish proceeds from the new shares from any proceeds received by selling shareholders.
Alongside the public offering, AMD, Broadcom, Google, Micron, Microsoft, NVIDIA and TSMC Partners agreed to buy Class N shares for a total of $26 billion. The private placement is priced at the same per-share price as the IPO, according to the disclosure. The deal adds substantial private financing to the proposed sale, but involves a different class of shares from the Class A shares offered to the public. The filing presents both transactions as part of the financing structure accompanying the listing. The amendment does not state a final price for either share class before registration and pricing procedures are complete.
Against the backdrop of the offering, the company’s prospectus showed revenue of $33.2 billion for the nine months ended Sept. 30, 2026, compared with $2.5 billion in the same period in 2025. The operating deficit narrowed to $1.3 billion in the nine months from $5.2 billion a year earlier. But the company recorded an operating loss of $567 million in the quarter ended Sept. 30, 2026. Anthropic attributed the loss mainly to $5 billion in short-term contracted compute, alongside $2 billion in non-cash charges related to its donation-matching program. These items put compute costs and program-related charges among the factors affecting results for the period, despite revenue growth and a narrower operating loss on a nine-month basis.
A Reuters report cited sell-side analysts’ estimates for Anthropic revenue of $52 billion to $53 billion in 2026, rising to $135 billion to $137 billion in 2027. These are analysts’ estimates, not financial results announced by the company. The report said the roadshow was scheduled to continue through the following Wednesday, when the deal was expected to be priced, and that its sources described early demand as strong and expected the order book to grow as the roadshow progressed. It also reported that investors were weighing rapid revenue growth against doubts about the company’s long-term competitive position. These concerns include its ability to continue charging high prices if competitors offer similar models.
Class A shares were approved for listing on the Nasdaq Global Select Market under the symbol ANT, according to the prospectus. But listing approval does not mean sales to the public have already begun. Anthropic said when launching the roadshow that the filed registration statement had not yet become effective and that shares could not be sold before it did. The Nov. 17 amendment tied the start of sales to the earliest practicable time after the registration statement became effective, without specifying a fixed date. The start of sales therefore remains linked to completion of that step, while the filing sets out the approved symbol and market for the listing.